Most active investors · Jan 1, 2026 – Oct 26, 2026
Ranked by rounds participated in, from announcements in Jan 1, 2026 – Oct 26, 2026. Lead counts include only confirmed lead roles.
Browse by month
Details
Details
New companies 2 · Follow-on 0
Stages: Seed 1, Series A 1
Gizmo $22M Series ATraining All People (TAP) Undisclosed SeedDetails
New companies 2 · Follow-on 0
Stages: Series C+ 2
Alloy Therapeutics $40M Series ETeraWatt Technology Undisclosed Series CDetails
New companies 2 · Follow-on 0
Stages: Seed 1, Series A 1
Capsule Security $7M SeedORION Security $32M Series ADetails
New companies 2 · Follow-on 0
Stages: Series A 2
Keebler Health $16M Series AThink Bioscience $55M Series ADetails
New companies 2 · Follow-on 0
Stages: Pre-seed 1, Series A 1
Keebler Health $16M Series AMaestro AI $1.2M Pre-SeedDetails
New companies 2 · Follow-on 0
Stages: Pre-seed 1, Undisclosed 1
Graftcode €2.1M UndisclosedReplenit $2.5M Pre-SeedDetails
New companies 2 · Follow-on 0
Stages: Seed 1, Undisclosed 1
Modern Relay $3M UndisclosedKinfolk $7.2M SeedDetails
New companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Adcendo $75M Series CMirador Therapeutics $250M Series BDetails
New companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
AlixLabs €15M Series APolar Light Technologies €5M UndisclosedDetails
New companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Synera $40M Series BVoiceLine €10M Series ADetails
New companies 2 · Follow-on 0
Stages: Series C+ 1, Undisclosed 1
Slate Auto $650M Series CBluePath Finance Undisclosed StrategicDetails
New companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
Vivatides Therapeutics $54M Series ASkild AI $1.4B UndisclosedDetails
Details
New companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
PIT IN Undisclosed Series A — initial funding; final close pendingVideo Rebirth $30M StrategicDetails
New companies 1 · Follow-on 1
Stages: Series C+ 1, Undisclosed 1
Oricell Therapeutics $110M Pre-IPOOricell Therapeutics $70M Series C1Details
Details
New companies 1 · Follow-on 1
Stages: Series C+ 1, Undisclosed 1
Oricell Therapeutics $110M Pre-IPOOricell Therapeutics $70M Series C1Details
New companies 2 · Follow-on 0
Stages: Series B 2
Membrane Technology & Research $27M Series BHydrosat $60M Series B and additional equityDetails
Details
New companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
RAAPID Undisclosed StrategicNeurophos $110M Series ADetails
Details
New companies 1 · Follow-on 1
Stages: Series C+ 1, Undisclosed 1
Oricell Therapeutics $110M Pre-IPOOricell Therapeutics $70M Series C1Details
New companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Sidewinder Therapeutics $137M Series BThird Arc Bio $52M Series A+Details
New companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
Sora Fuel $14.6M UndisclosedCocoon Carbon $15M Series ADetails
New companies 2 · Follow-on 0
Stages: Seed 1, Undisclosed 1
Alphy Undisclosed StrategicDerapi $7M SeedDetails
New companies 2 · Follow-on 0
Stages: Series C+ 1, Undisclosed 1
Hermeus $350M Series CVieCure $43M UndisclosedDetails
New companies 2 · Follow-on 0
Stages: Pre-seed 1, Undisclosed 1
Ridge AI $2.6M Pre-SeedUnited Manufacturing Hub €5M UndisclosedDetails
New companies 2 · Follow-on 0
Stages: Seed 2
Hybron Technologies $20M SeedVICTUS Technologies Undisclosed Seed“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.